Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.

Imatinib

Targeted Therapy2001
Drug ClassTargeted Therapy
Year Approved2001
Conditions TreatedCML, GIST
AvailabilityPrescription

About Imatinib

A breakthrough targeted cancer therapy. Imatinib or Gleevec treats chronic myeloid leukemia by specifically inhibiting the BCR ABL fusion protein that drives the cancer. Before imatinib, CML was usually fatal within several years. Imatinib transformed CML into a manageable chronic condition with near normal life expectancy for many patients. It was hailed as a miracle drug and became the model for targeted cancer therapy. Imatinib also treats gastrointestinal stromal tumors. The drug demonstrated that understanding cancer genetics could lead to highly effective treatments.

Related Medications